RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00033348.xml
PDF herunterladen
CC BY-NC-ND 4.0 · Journal of Clinical Interventional Radiology ISVIR 2023; 07(01): 034-045
DOI: 10.1055/s-0042-1748818
DOI: 10.1055/s-0042-1748818
Review Article
Expanding Indications of TIPS in the Management of Portal Hypertension Complications
Abstract
Transjugular intrahepatic portosystemic shunt (TIPS) is a nonsurgical intervention to reduce portal pressure by creating a low-resistance channel between the portal and systemic circulations. It is a well-accepted treatment for gastroesophageal varices and refractory ascites. This review aims to discuss the evidence-based applications of TIPS in other complications of portal hypertension beyond gastroesophageal varices and refractory ascites.
Publikationsverlauf
Artikel online veröffentlicht:
31. Mai 2022
© 2022. Indian Society of Vascular and Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Pinchot JW, Kalva SP, Majdalany BS. et al; Expert Panels on Interventional Radiology and Vascular Imaging. ACR Appropriateness Criteria® radiologic management of portal hypertension. J Am Coll Radiol 2021; 18 (5S): S153-S173
- 2 Augustin S, Millán L, González A. et al. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study. J Hepatol 2014; 60 (03) 561-569
- 3 Tripathi D, Stanley AJ, Hayes PC. et al. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut 2020; 69 (07) 1173-1192
- 4 Smith M, Durham J. Evolving indications for tips. Tech Vasc Interv Radiol 2016; 19 (01) 36-41
- 5 Ditah IC, Al Bawardy BF, Saberi B, Ditah C, Kamath PS. Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: a systematic review and cumulative meta-analysis. World J Hepatol 2015; 7 (13) 1797-1806
- 6 Rajesh S, George T, Philips CA. et al. Transjugular intrahepatic portosystemic shunt in cirrhosis: an exhaustive critical update. World J Gastroenterol 2020; 26 (37) 5561-5596
- 7 Garbuzenko DV, Arefyev NO. Hepatic hydrothorax: an update and review of the literature. World J Hepatol 2017; 9 (31) 1197-1204
- 8 Campos S, Gomes D, Sofia C. Transjugular intrahepatic portosystemic shunt in refractory hydrothorax - a contribution to an unexplored indication. Eur J Gastroenterol Hepatol 2016; 28 (06) 661-666
- 9 Chow E, Khiatah B, Frugoli A. Refractory spontaneous bacterial empyema in cirrhotic patient. Case Rep Gastrointest Med 2021. 2021 :6685998
- 10 Jindal A, Mukund A, Kumar G, Sarin SK. Efficacy and safety of transjugular intrahepatic portosystemic shunt in difficult-to-manage hydrothorax in cirrhosis. Liver Int 2019; 39 (11) 2164-2173
- 11 Garcia-Pagán JC, Heydtmann M, Raffa S. et al; Budd-Chiari Syndrome-Transjugular Intrahepatic Portosystemic Shunt Group. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008; 135 (03) 808-815
- 12 Martens P, Nevens F. Budd-Chiari syndrome. United European Gastroenterol J 2015; 3 (06) 489-500
- 13 Sonavane AD, Amarapurkar DN, Rathod KR, Punamiya SJ. Long term survival of patients undergoing TIPS in Budd-Chiari syndrome. J Clin Exp Hepatol 2019; 9 (01) 56-61
- 14 Ryu RK, Durham JD, Krysl J. et al. Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome. J Vasc Interv Radiol 1999; 10 (06) 799-805
- 15 McCarthy PM, van Heerden JA, Adson MA, Schafer LW, Wiesner RH. The Budd-Chiari syndrome. Medical and surgical management of 30 patients. Arch Surg 1985; 120 (06) 657-662
- 16 Mancuso A. An update on the management of Budd-Chiari syndrome: the issues of timing and choice of treatment. Eur J Gastroenterol Hepatol 2015; 27 (03) 200-203
- 17 Lupasco I, Dumbrava V-T. Diagnosis and therapy of Budd Chiari syndrome. Med Pharm Rep 2021; 94 (Suppl No 1): S68-S71
- 18 Inchingolo R, Posa A, Mariappan M. et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: a comprehensive review. World J Gastroenterol 2020; 26 (34) 5060-5073
- 19 Fitsiori K, Tsitskari M, Kelekis A, Filippiadis D, Triantafyllou K, Brountzos E. Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: results from a single center. Cardiovasc Intervent Radiol 2014; 37 (03) 691-697
- 20 Tripathi D, Macnicholas R, Kothari C. et al. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. Aliment Pharmacol Ther 2014; 39 (08) 864-872
- 21 Hayek G, Ronot M, Plessier A. et al. Long-term outcome and analysis of dysfunction of transjugular intrahepatic portosystemic shunt placement in chronic primary Budd-Chiari syndrome. Radiology 2017; 283 (01) 280-292
- 22 Seijo S, Plessier A, Hoekstra J. et al; European Network for Vascular Disorders of the Liver. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology 2013; 57 (05) 1962-1968
- 23 Sharma AM, Zhu D, Henry Z. Portal vein thrombosis: when to treat and how?. Vasc Med 2016; 21 (01) 61-69
- 24 Chamarthy MR, Anderson ME, Pillai AK, Kalva SP. Thrombolysis and transjugular intrahepatic portosystemic shunt creation for acute and subacute portal vein thrombosis. Tech Vasc Interv Radiol 2016; 19 (01) 42-51
- 25 Rodrigues SG, Sixt S, Abraldes JG. et al. Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis. Aliment Pharmacol Ther 2019; 49 (01) 20-30
- 26 Loffredo L, Pastori D, Farcomeni A, Violi F. Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis. Gastroenterology 2017; 153 (02) 480-487.e1
- 27 Zhan C, Prabhu V, Kang SK. et al. Comparison of non-tumoral portal vein thrombosis management in cirrhotic patients: TIPS versus anticoagulation versus no treatment. J Clin Med 2021; 10 (11) 2316
- 28 Luo J, Li M, Zhang Y. et al. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy. Eur Radiol 2018; 28 (09) 3661-3668
- 29 Ferrusquía-Acosta J, Hernández-Gea V. TIPS indications and contraindications—pushing the limits: is earlier better?. Curr Hepatol Rep 2019; 18 (01) 87-95
- 30 Valentin N, Korrapati P, Constantino J, Young A, Weisberg I. The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2018; 30 (10) 1187-1193
- 31 Keshava SN, Moses V, Sharma A. et al. Technical and medium-term clinical outcomes of transjugular intrahepatic portosystemic shunt with fluoroscopy and additional trans-abdominal ultrasound guidance. Indian J Radiol Imaging 2021; 31 (04) 858-866
- 32 Guevara M, Ginès P, Bandi JC. et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998; 28 (02) 416-422
- 33 Amin AA, Alabsawy EI, Jalan R, Davenport A. Epidemiology, pathophysiology, and management of hepatorenal syndrome. Semin Nephrol 2019; 39 (01) 17-30
- 34 Arroyo V, Ginès P, Gerbes AL. et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23 (01) 164-176
- 35 Angeli P, Ginès P, Wong F. et al; International Club of Ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut 2015; 64 (04) 531-537
- 36 Rössle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 2010; 59 (07) 988-1000
- 37 Song T, Rössle M, He F, Liu F, Guo X, Qi X. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: a systematic review and meta-analysis. Dig Liver Dis 2018; 50 (04) 323-330
- 38 Charilaou P, Devani K, Petrosyan R, Reddy C, Pyrsopoulos N. Inpatient mortality benefit with transjugular intrahepatic portosystemic shunt for hospitalized hepatorenal syndrome patients. Dig Dis Sci 2020; 65 (11) 3378-3388
- 39 Ripoll C, Garcia-Tsao G. The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis 2011; 43 (05) 345-351
- 40 Mezawa S, Homma H, Ohta H. et al. Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation. Am J Gastroenterol 2001; 96 (04) 1155-1159
- 41 Kamath PS, Lacerda M, Ahlquist DA, McKusick MA, Andrews JC, Nagorney DA. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000; 118 (05) 905-911
- 42 Choi YH, Yoon CJ, Park JH, Chung JW, Kwon JW, Choi GM. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol 2003; 4 (02) 109-116
- 43 Lipnik AJ, Pandhi MB, Khabbaz RC, Gaba RC. Endovascular treatment for variceal hemorrhage: TIPS, BRTO, and combined approaches. Semin Intervent Radiol 2018; 35 (03) 169-184
- 44 Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16 (06) 1343-1349
- 45 Morrison JD, Mendoza-Elias N, Lipnik AJ. et al. Gastric varices bleed at lower portosystemic pressure gradients than esophageal varices. J Vasc Interv Radiol 2018; 29 (05) 636-641
- 46 Kim SK, Lee KA, Sauk S, Korenblat K. Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde transvenous obliteration in managing isolated gastric varices. Korean J Radiol 2017; 18 (02) 345-354
- 47 Wang ZW, Liu JC, Zhao F. et al. Comparison of the effects of TIPS versus BRTO on bleeding gastric varices: a meta-analysis. Can J Gastroenterol Hepatol. 2020 2020 5143013
- 48 Kochar N, Tripathi D, McAvoy NC, Ireland H, Redhead DN, Hayes PC. Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts. Aliment Pharmacol Ther 2008; 28 (03) 294-303
- 49 Norton ID, Andrews JC, Kamath PS. Management of ectopic varices. Hepatology 1998; 28 (04) 1154-1158
- 50 Akhter NM, Haskal ZJ. Diagnosis and management of ectopic varices. Gastrointestinal Intervention 2012; 1 (01) 3-10
- 51 Oey RC, de Wit K, Moelker A. et al. Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study. Aliment Pharmacol Ther 2018; 48 (09) 975-983
- 52 Vangeli M, Patch D, Terreni N. et al. Bleeding ectopic varices–treatment with transjugular intrahepatic porto-systemic shunt (TIPS) and embolisation. J Hepatol 2004; 41 (04) 560-566
- 53 Sellers CM, Nezami N, Schilsky ML, Kim HS. Transjugular intrahepatic portosystemic shunt as a bridge to liver transplant: current state and future directions. Transplant Rev (Orlando) 2019; 33 (02) 64-71
- 54 Valdivieso A, Ventoso A, Gastaca M. et al. Does the transjugular intrahepatic portosystemic influence the outcome of liver transplantation? Transplant Proc. 2012; 44 (06) 1505-1507
- 55 Mumtaz K, Metwally S, Modi RM. et al. Impact of transjugular intrahepatic porto-systemic shunt on post liver transplantation outcomes: study based on the United Network for Organ Sharing database. World J Hepatol 2017; 9 (02) 99-105
- 56 Chen B, Wang W, Tam MD, Quintini C, Fung JJ, Li X. Transjugular intrahepatic portosystemic shunt in liver transplant recipients: indications, feasibility, and outcomes. Hepatol Int 2015; 9 (03) 391-398
- 57 Lerut JP, Goffette P, Molle G. et al. Transjugular intrahepatic portosystemic shunt after adult liver transplantation: experience in eight patients. Transplantation 1999; 68 (03) 379-384
- 58 King A, Masterton G, Gunson B. et al. A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation. Liver Transpl 2011; 17 (07) 771-778
- 59 Boike JR, Flamm SL. Transjugular intrahepatic portosystemic shunts: advances and new uses in patients with chronic liver disease. Clin Liver Dis 2020; 24 (03) 373-388
- 60 Tabchouri N, Barbier L, Menahem B. et al. Original study: transjugular intrahepatic portosystemic shunt as a bridge to abdominal surgery in cirrhotic patients. J Gastrointest Surg 2019; 23 (12) 2383-2390
- 61 Vinet E, Perreault P, Bouchard L. et al. Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study. Can J Gastroenterol 2006; 20 (06) 401-404
- 62 Grilo-Bensusan I, Pascasio-Acevedo JM. Hepatopulmonary syndrome: what we know and what we would like to know. World J Gastroenterol 2016; 22 (25) 5728-5741
- 63 Wallace MC, James AL, Marshall M, Kontorinis N. Resolution of severe hepato-pulmonary syndrome following transjugular portosystemic shunt procedure. BMJ Case Rep 2012; 2012: bcr0220125811
- 64 Tsauo J, Zhao H, Zhang X. et al. Effect of transjugular intrahepatic portosystemic shunt creation on pulmonary gas exchange in patients with hepatopulmonary syndrome: a prospective study. J Vasc Interv Radiol 2019; 30 (02) 170-177
- 65 Qi X, Yang M, Fan D, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures. Scand J Gastroenterol 2013; 48 (07) 771-784
- 66 Qi X, Guo W, He C. et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int 2014; 34 (08) 1164-1175
- 67 Fan X, Liu K, Che Y. et al. Good clinical outcomes in Budd–Chiari syndrome with hepatic vein occlusion. Dig Dis Sci 2016; 61 (10) 3054-3060
- 68 Rosenqvist K, Sheikhi R, Eriksson L-G. et al. Endovascular treatment of symptomatic Budd-Chiari syndrome - in favour of early transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol 2016; 28 (06) 656-660
- 69 Chen Y, Ye P, Li Y, Ma S, Zhao J, Zeng Q. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications. Eur Radiol 2015; 25 (12) 3431-3437
- 70 Sun X-Y, Wang G-C, Wang J, Huang G-J, Zhang C-Q. Transjugular intrahepatic portosystemic shunt is effective in patients with chronic portal vein thrombosis and variceal bleeding. Hepatobiliary Pancreat Dis Int 2021; 20 (02) 128-136
- 71 Brensing KA, Textor J, Perz J. et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000; 47 (02) 288-295
- 72 Vidal V, Joly L, Perreault P, Bouchard L, Lafortune M, Pomier-Layrargues G. Usefulness of transjugular intrahepatic portosystemic shunt in the management of bleeding ectopic varices in cirrhotic patients. Cardiovasc Intervent Radiol 2006; 29 (02) 216-219
- 73 Amesur NB, Zajko AB, Orons PD, Sammon JK, Casavilla FA. Transjugular intrahepatic portosystemic shunt in patients who have undergone liver transplantation. J Vasc Interv Radiol 1999; 10 (05) 569-573
- 74 Tsauo J, Weng N, Ma H, Jiang M, Zhao H, Li X. Role of transjugular intrahepatic portosystemic shunts in the management of hepatopulmonary syndrome: a systemic literature review. J Vasc Interv Radiol 2015; 26 (09) 1266-1271